P199: Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2047-2994
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
P199: Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus ; volume:2 ; number:1 ; day:20 ; month:6 ; year:2013 ; pages:1 ; date:6.2013
Antimicrobial resistance and infection control ; 2, Heft 1 (20.6.2013), 1, 6.2013

Urheber
Lee, MS
Beteiligte Personen und Organisationen
Park, KH
Jung, MH
Kim, YS
SpringerLink (Online service)

DOI
10.1186/2047-2994-2-S1-P199
URN
urn:nbn:de:1111-2016072645304
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:00 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Lee, MS
  • Park, KH
  • Jung, MH
  • Kim, YS
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Methicillin-Resistant Staphylococcus aureus Vertebral Osteomyelitis Following Epidural Catheterization: A Case Report and Literature Review

Methicillin-Resistant Staphylococcus aureus Vertebral Osteomyelitis Following Epidural Catheterization: A Case Report and Literature Review

Comparison of clinical features and outcomes of staphylococcus aureus vertebral osteomyelitis caused by methicillin-resistant and methicillin-sensitive strains

Comparison of clinical features and outcomes of staphylococcus aureus vertebral osteomyelitis caused by methicillin-resistant and methicillin-sensitive strains

Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin

Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin

Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis

Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis

Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)

Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)

USA300 Methicillin-resistant Staphylococcus aureus in Cuba

USA300 Methicillin-resistant Staphylococcus aureus in Cuba

Methicillin-Resistant Staphylococcus aureus–Associated Infections following Septorhinoplasty

Methicillin-Resistant Staphylococcus aureus–Associated Infections following Septorhinoplasty

Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs

Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs

Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model

Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model

Delayed methicillin-resistant Staphylococcus aureus-induced osteomyelitis of the tibia after pin tract infection: two case reports

Delayed methicillin-resistant Staphylococcus aureus-induced osteomyelitis of the tibia after pin tract infection: two case reports

Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond

Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond

Methicillin-resistant Staphylococcus aureus without borders: USA300 in Cuba

Methicillin-resistant Staphylococcus aureus without borders: USA300 in Cuba

Verbundene Objekte